THE TGA has issued a safety alert stating that the oral antihistamine promethazine hydrochloride, sold as Phenergan and other generic brands, should not be given to children under six years of age.
Sanofi-Aventis Healthcare has updated its PI and CMI documents to include risks of psychiatric and central nervous system effects.
Other brands are also required to update their documentation and labelling.
The above article was sent to subscribers in Pharmacy Daily's issue from 22 Nov 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 Nov 24